Search Results
Aug 20, 2026, 09:37 ET Capricor Therapeutics, Inc. (CAPR) Investors: September 28, 2026 Lead Plaintiff Deadline in Class Action Lawsuit
2026 /PRNewswire/ -- National investor rights law firm Hagens Berman highlights developments surrounding Capricor Therapeutics, Inc. (NASDAQ: CAPR). Following Capricor's recent Q2 2026 earnings release and conference call—notable for an omission of management Q&A with analysts—the company
More news about: Hagens Berman Sobol Shapiro LLP
Aug 19, 2026, 15:00 ET Capricor Therapeutics, Inc. (CAPR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
The Law Offices of Frank R. Cruz announces that investors with losses related to Capricor Therapeutics, Inc. (CAPR) have opportunity to lead the securities fraud class action lawsuit.
More news about: The Law Offices of Frank R. Cruz, Los Angeles
Aug 19, 2026, 13:10 ET CAPR Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Capricor Therapeutics Securities Lawsuit - Contact Levi & Korsinsky
LLP provides context on investor sentiment surrounding Capricor Therapeutics, Inc. (NASDAQ: CAPR) and notifies shareholders that a securities class action has been filed on behalf of investors who purchased CAPR securities between December 17, 2025 and July 26, 2026.
More news about: Levi & Korsinsky, LLP
Aug 19, 2026, 02:43 ET CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit
2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between December 17, 2025 and July 26, 2026, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff deadline.
More news about: THE ROSEN LAW FIRM, P. A.
Aug 18, 2026, 10:11 ET Lost Money on Capricor Therapeutics, Inc. (CAPR)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm
Aug. 18, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Capricor Therapeutics, Inc. (NASDAQ: CAPR).
More news about: The Gross Law Firm
Aug 18, 2026, 06:17 ET CAPR Stock News: Capricor Therapeutics Sued for Securities Fraud over Alleged Misrepresentations and Corresponding 64% Stock Drop
multimedia:https://www.prnewswire.com/news-releases/capr-stock-news-capricor-therapeutics-sued-for-securities-fraud-over-alleged-misrepresentations-and-corresponding-64-stock-drop-302853484.htmlSOURCE
More news about: Bleichmar Fonti & Auld LLP
Aug 18, 2026, 06:15 ET CAPR Stock Alert: Capricor Therapeutics, Inc. (CAPR) Reports Q2 Earnings Amid Ongoing Securities Class Action Lawsuit - Hagens Berman
2026 /PRNewswire/ -- National investor rights law firm Hagens Berman highlights developments surrounding Capricor Therapeutics, Inc. (NASDAQ: CAPR). Following Capricor's recent Q2 2026 earnings release and conference call—notable for an omission of management Q&A with analysts—the company
More news about: Hagens Berman Sobol Shapiro LLP
Aug 17, 2026, 04:36 ET Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CAPR
CAPR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of CAPR during the class period listed are encouraged
More news about: DJS Law Group LLP
Aug 17, 2026, 03:30 ET CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law
CAPR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of CAPR during the class period listed are encouraged
More news about: Schall, Brown & Schwartz LLP
Aug 16, 2026, 19:55 ET CAPR Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages CAPR Investors with Losses to Contact the Firm
Did you buy CAPR securities between December 17, 2025 and July 26, 2026?Affected CAPR Investor SummaryWho: Capricor Therapeutics, Inc. (
More news about: Kessler Topaz Meltzer & Check, LLP
Aug 14, 2026, 22:00 ET Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NasdaqGS: CAPR) of a class action securities lawsuit.
More news about: Kahn Swick & Foti, LLC
Aug 14, 2026, 15:38 ET Capricor Therapeutics, Inc. (CAPR) Investors: September 28, 2026 Lead Plaintiff Deadline in Class Action Lawsuit - Hagens Berman
Aug. 14, 2026 /PRNewswire/ -- Hagens Berman encourages investors in Capricor Therapeutics, Inc. (NASDAQ: CAPR) who suffered substantial losses to
More news about: Hagens Berman Sobol Shapiro LLP
Aug 13, 2026, 21:59 ET CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit
Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between December 17, 2025 and July 26, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as
More news about: THE ROSEN LAW FIRM, P. A.
Aug 13, 2026, 12:37 ET CAPR Deadline Alert: SueWallSt Reminds Capricor Therapeutics, Inc. (CAPR) Investors of Securities Class Action Deadline on September 28, 2026
securities litigation firms in the United States.Frequently Asked Questions About the CAPR LawsuitQ: Who is eligible to join the CAPR investor lawsuit? A: Investors who purchased CAPR stock or securities between December 17, 2025 and July 26, 2026 and suffered financial losses
More news about: SueWallSt.com
Aug 13, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Capricor Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - CAPR
/PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
Aug 13, 2026, 05:04 ET CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law
CAPR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of CAPR during the class period listed are encouraged
More news about: Schall, Brown & Schwartz LLP
Aug 13, 2026, 04:12 ET Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CAPR
CAPR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of CAPR during the class period listed are encouraged
More news about: DJS Law Group LLP
Aug 12, 2026, 19:30 ET INVESTOR ALERT: Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit
Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Capricor Therapeutics, Inc. (NASDAQ: CAPR) securities between December 17, 2025 and July 26, 2026, inclusive (the "Class Period"), have until September 28, 2026 to seek appointment as lead plaintiff
More news about: Robbins Geller Rudman & Dowd LLP
Aug 12, 2026, 13:15 ET CAPR Alert: Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed, September 28, 2026 Lead Plaintiff Deadline
Aug. 12, 2026 /PRNewswire/ -- Hagens Berman encourages investors in Capricor Therapeutics, Inc. (NASDAQ: CAPR) who suffered substantial losses to
More news about: Hagens Berman Sobol Shapiro LLP
Aug 12, 2026, 10:07 ET CAPR UPCOMING DEADLINE: Levi & Korsinsky Alerts Capricor Therapeutics, Inc. Stockholders of Securities Class Action - Contact the Firm
dollars for aggrieved shareholders. Ranked in ISS Top 50 for seven consecutive years.Frequently Asked Questions About the CAPR LawsuitQ: How much did CAPR stock drop? A: Shares fell approximately 78.7%, a decline of an aggregate $15.08 per share across two corrective disclosures,
More news about: Levi & Korsinsky, LLP
Aug 11, 2026, 10:17 ET CAPR Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Capricor Therapeutics, Inc. Securities Lawsuit - Contact The Gross Law Firm
Aug. 11, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Capricor Therapeutics, Inc. (NASDAQ: CAPR).
More news about: The Gross Law Firm
Aug 11, 2026, 07:07 ET CAPR Investor Announcement: Capricor Therapeutics Sued on behalf of Investors to Recover Losses after Clinical Data Leads to 64% Stock Drop
multimedia:https://www.prnewswire.com/news-releases/capr-investor-announcement-capricor-therapeutics-sued-on-behalf-of-investors-to-recover-losses-after-clinical-data-leads-to-64-stock-drop-302847793.htmlSOURCE
More news about: Bleichmar Fonti & Auld LLP
Aug 11, 2026, 06:30 ET CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit
Aug. 11, 2026 /PRNewswire/ -- Hagens Berman encourages investors in Capricor Therapeutics, Inc. (NASDAQ: CAPR) who suffered substantial losses to
More news about: Hagens Berman Sobol Shapiro LLP
Aug 10, 2026, 08:26 ET Berger Montague PC Investigating Claims on Behalf of Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors After Class Action Filing
Berger Montague PC announces a class action lawsuit against Capricor Therapeutics, Inc. (NASDAQ: CAPR) ("Capricor" or the "Company") on behalf of investors who purchased or acquired Capricor securities during the period from December 17, 2025 through
More news about: Berger Montague
Aug 10, 2026, 08:22 ET CAPR Alert: Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed, September 28, 2026 Lead Plaintiff Deadline
2026 /PRNewswire/ -- Hagens Berman encourages investors in Capricor Therapeutics, Inc. (NASDAQ: CAPR) who suffered substantial losses to
More news about: Hagens Berman Sobol Shapiro LLP